Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ZARS is granted marketing authorization for Rapydan in 11 European countries

March 3, 2008

Preclinical profile of GRL-8234 reported by Comentis

March 3, 2008

Not approvable letter for Zyprexa long-acting injection in schizophrenia

March 3, 2008

XenoPort and GSK report positive results from phase III trial of XP-13512

March 3, 2008

Impaired cognition in diabetes associated with increased cortisol levels

March 3, 2008

Recent patents divulge novel analgesic agents

March 3, 2008

Preclinical profile of Pfizer's novel CRF1 receptor antagonist CP-376395

March 3, 2008

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Feb. 29, 2008

Preliminary results reported from phase III NGX-4010 trial in HIV-DSP

Feb. 29, 2008

Positive pharmacokinetic study results of once-daily ondansetron

Feb. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...